In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice. Together with colleagues from eleven countries, an internationally standardized scoring method was established.
With over a million new cases per year, colorectal cancer is one of the most commonly diagnosed cancers across the globe. Despite recent advances in medical research, the prognosis of patients who present with advanced tumors remains relatively poor.
The treatment of colorectal cancer requires an interdisciplinary approach. After surgery is performed to remove the cancer with part of the colon, the specimen is then examined by a physician with specialist training pathology who is responsible for confirming the diagnosis and determining tumor stage.
Additionally, in order to evaluate the biological behavior of an individual tumor the pathologist can also examine certain biomarkers, either microscopically or by additional molecular analysis. The information from such biomarkers may be of prognostic value, or predict response to a given therapy, so that treatment strategies can be tailored to individual patients.
Biomarkers for more precise prognosis
The phenomenon of ‘tumor budding’ has received increasing attention in the medical literature as an indicator of aggressiveness in colorectal cancer. Single cancer cells or small clusters of cancer cells gain the ability to detach from the main tumor body and increase the risk of colonization of other organs via lymphatic and blood vessels, ultimately leading to fatality.
However, until now, there has been no established and internationally recognized system to assess tumor budding in order for it to be used to influence clinical management decisions that directly affect patient care.
Bernese efforts to achieve consensus
At the end of April 2016, an international tumor budding consensus conference (ITBCC) initiated by the Colorectal Cancer Research Group was held in order to develop an internationally standardized method of assessing tumor buds. The method is cheap, can be performed anywhere and can replace in some circumstances expensive molecular testing.
This was a revolutionary step in improving biomarker assessment in colorectal cancer. The next step is to implement tumor budding as a prognostic indicator in national guidelines as well as colorectal cancer reporting recommendations of the World Health Organization (WHO), the UICC (Union Intérnationale Contre le Cancer) and the AJCC (American Joint Committee on Cancer).
«Reporting of tumor budding by pathologists worldwide will help serve as the basis for future clinical studies geared at the development of novel therapies targeted at tumor buds», says Alessandro Lugli, Head of the Division of Clinical Pathology at the Institute of Pathology.
Nathalie Matter | Universität Bern
Chronic stress induces fatal organ dysfunctions via a new neural circuit
21.08.2017 | Hokkaido University
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
21.08.2017 | Materials Sciences
21.08.2017 | Health and Medicine
21.08.2017 | Materials Sciences